CIK 0001956827 · Pharmaceutical Preparations (SIC 2834) · Nasdaq, OTC · incorporated in I0 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-21 | F-6EF | F-6EF | |
| 2026-09-21 | 6-K | 6-K | 2026-06-30 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-06 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-07-02 | 6-K | 6-K | 2026-07-02 |
| 2026-07-02 | 424B5 | 424B5 | |
| 2026-07-01 | FWP | FWP | |
| 2026-06-30 | FWP | FWP | |
| 2026-06-30 | 424B5 | 424B5 | |
| 2026-06-30 | POSASR | POSASR | |
| 2026-06-29 | 6-K | 6-K | 2026-06-29 |
| 2026-06-02 | 6-K | 6-K | 2026-06-01 |
| 2026-05-22 | 6-K | 6-K | 2026-03-31 |
| 2026-05-20 | 6-K | 6-K | 2026-05-20 |
| 2026-05-11 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-05-07 | 6-K | 6-K | 2026-05-07 |
| 2026-05-07 | 424B7 | 424B7 | |
| 2026-04-20 | 6-K | 6-K | 2026-04-20 |
| 2026-03-23 | S-8 | S-8 | |
| 2026-03-23 | 20-F | 20-F | 2025-12-31 |
| 2026-03-23 | 6-K | 6-K | 2025-12-31 |
| 2026-02-23 | 6-K | 6-K | 2026-02-21 |
| 2026-02-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-01-14 | SCHEDULE 13D/A | SCHEDULE 13D/A |
Forms on file (last 1,000): 6-K 36, SCHEDULE 13G/A 6, SCHEDULE 13D/A 6, CORRESP 6, UPLOAD 6, FWP 5, 424B5 4, 20-F 3. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ABVX (0.002 USD), /gw/filings/filings?ticker=ABVX&form=8-K, /gw/filings/facts?ticker=ABVX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange